The impact upon extra-pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia

---

Autoria(s): Ritchie, C. W.; Chiu, E.; Harrigan, S.; Hall, K.; Hassett, A.; Macfarlane, S.; Mastwyk, M.; O’Connor, D. W.; Opie, J.; Ames, D.

Data(s)	01/01/2003
Identificador	http://hdl.handle.net/10536/DRO/DU:30052320
Idioma(s)	eng
Publicador	John Wiley & Sons
Relação	http://dro.deakin.edu.au/eserv/DU:30052320/hall-impactupon-2003.pdf http://dx.doi.org/10.1002/gps.862
Palavras-Chave	#schizophrenia #elderly #olanzapine #risperidone #extra-pyramidal side-effects #quality of life #switching
Tipo	Journal Article